CAMBRIDGE, Mass., September 26, 2024--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it will webcast its upcoming TTR Investor Day event on the Investors section of the Company’s website, www.alnylam.com, on Wednesday, October 9, 2024 at 8:30 am ET. A replay will be available on the Alnylam website within 48 hours after the event.
The market has climbed 1.0% in the last 7 days and is up 28% over the past 12 months, with earnings forecast to grow by 15% annually. In this dynamic environment, identifying high-growth tech stocks can be crucial for investors looking to capitalize on robust market performance and strong future earnings potential.
We recently compiled a list of the 10 Best Aggressive Growth Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) stands against the other aggressive growth stocks. If you’re putting money in the stock market, it’s more likely than not that growth […]